share_log

INVO Bioscience | 4: Statement of changes in beneficial ownership of securities-Chief Operating Officer Campbell Michael Jos.

SEC ·  May 23, 2023 07:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more